Martin Durec

Accounting Manager Canada & EMEA at Alnylam Pharmaceuticals - Cambridge, Massachusetts, US

Martin Durec's Colleagues at Alnylam Pharmaceuticals
Michiel Openneer

Key Account Manager Netherlands

Contact Michiel Openneer

Raquel Quental

Manager Distribution & Commercial Quality Assurance

Contact Raquel Quental

Grégory Lumsden

Senior Accountant CEMEA a.i.

Contact Grégory Lumsden

Charlotte Extergren

Country Medical Director, Nordics

Contact Charlotte Extergren

View All Martin Durec's Colleagues
Martin Durec's Contact Details
HQ
(617) 551-8200
Location
Amsterdam Area, Netherlands
Company
Alnylam Pharmaceuticals
Martin Durec's Company Details
Alnylam Pharmaceuticals logo, Alnylam Pharmaceuticals contact details

Alnylam Pharmaceuticals

Cambridge, Massachusetts, US • 2460 Employees
SaaS

ALNYLAM IS LEADING THE RNAi REVOLUTION™ Alnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them. Founded in 2002 by a group of distinguished researchers and biotech leaders, Alnylam’s work over more than two decades has yielded the critical breakthroughs and advancements that have made the field of (RNAi) therapeutics possible. In 2018, our first commercial medicine, and the world’s first RNAi therapeutic was approved. Since then, four more Alnylam-developed medicines have been approved and we’re hard at work developing new therapies to treat both rare and prevalent diseases. We are a global and diverse company of 2,500+ people. We pride ourselves on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That's why we’re consistently ranked as a top employer by The Boston Globe (2015-23), Science Magazine (2018-23), Fast Company (Best Workplaces for Innovators 2020-23) and LinkedIn (2024). We are based in Cambridge, Massachusetts (U.S.), with offices throughout North America, Europe, Asia, and South America. See our social media community guidelines: https://bit.ly/2FcRhJy. Please note: If you wish to report an adverse event or product complaint, please email medinfo@alnylam.com or you may call us using the following telephone numbers: for North America, 877.ALNYLAM (877.256.9526), for Europe, +31 20 369 7861

Rna Therapeutics Innovative Treatments Ocular Disease Treatment
Details about Alnylam Pharmaceuticals
Frequently Asked Questions about Martin Durec
Martin Durec currently works for Alnylam Pharmaceuticals.
Martin Durec's role at Alnylam Pharmaceuticals is Accounting Manager Canada & EMEA.
Martin Durec's email address is ***@alnylam.com. To view Martin Durec's full email address, please signup to ConnectPlex.
Martin Durec works in the SaaS industry.
Martin Durec's colleagues at Alnylam Pharmaceuticals are Michiel Openneer, Raquel Quental, Elena Veklenko, Grégory Lumsden, Charlotte Extergren, Kajsa Larsson, Scott Warren and others.
Martin Durec's phone number is (617) 551-8200
See more information about Martin Durec